OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
26
Results
Show all
Save search
Copy query
Show results for
Unknown
(26)
Publication Date
Release Date
2019
(6)
2015
(5)
2018
(4)
2020
(3)
2016
(3)
2017
(2)
2022
(1)
2021
(1)
2012
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals.
Not available
S-EPMC4887098
|
biostudies-literature
Cite
TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression.
Not available
S-EPMC4704461
|
biostudies-literature
Cite
Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis.
Not available
S-EPMC9174491
|
biostudies-literature
Cite
The Differential Effects of Anti-Diabetic Thiazolidinedione on Prostate Cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status.
Not available
S-EPMC4415117
|
biostudies-literature
Cite
Sorafenib with ASC-J9
®
synergistically suppresses the HCC progression via altering the pSTAT3-CCL2/Bcl2 signals.
Not available
S-EPMC5215679
|
biostudies-literature
Cite
TR4 nuclear receptor enhances prostate cancer initiation via altering the stem cell population and EMT signals in the PPARG-deleted prostate cells.
Not available
S-EPMC4381707
|
biostudies-literature
Cite
Preclinical study using circular RNA 17 and micro RNA 181c-5p to suppress the enzalutamide-resistant prostate cancer progression.
Not available
S-EPMC6425037
|
biostudies-literature
Cite
Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression.
Not available
S-EPMC6412086
|
biostudies-literature
Cite
The miR-92a-2-5p in exosomes from macrophages increases liver cancer cells invasion via altering the AR/PHLPP/p-AKT/β-catenin signaling.
Not available
S-EPMC7853149
|
biostudies-literature
Cite
Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals.
Not available
S-EPMC8257744
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets